Salary Range:CHF102,200.00 - CHF189,800.00 Job Description SummaryJob Title: Senior Expert (AI Engineering) #LI-Hybrid Location: Basel, Switzerland Relocation Support: This role is based in Basel, Switzerland. Novartis is unable to offer relocation support: please only apply if
Salary Range:CHF102,200.00 - CHF189,800.00 Job Description SummaryThe Senior Data Scientist & Scientific Software Engineer will join the Modeling & Simulation Data Science team within the Translational Medicine Unit to help advance data-driven drug discovery. The role
Salary Range:CHF93,800.00 - CHF174,200.00 Job Description Summary#LI-Hybrid Location: Basel, Switzerland This role is based in Basel, Switzerland. Novartis is unable to offer relocation support for this role. Please only apply if this location is accessible for
Salary Range:CHF126,000.00 - CHF234,000.00 Job Description Summary#LI-Hybrid Location: Basel, Switzerland This role is based in Basel, Switzerland. Novartis is unable to offer relocation support for this role. Please only apply if this location is accessible for
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Salary Range:CHF102,200.00 - CHF189,800.00 BandLevel 4 Job Description Summary#LI-Hybrid Location: Basel, Switzerland Internal Title: Data Scientist, Senior Expert I or II As a Senior Expert I/II, Data Science, you will join our Modeling & Simulation (M&S)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Our client is an international financial institution with a long?standing mandate to support global monetary and financial stability. Operating with a highly professional, multicultural workforce, the institution provides banking, asset?management, and analytical services to central banks